We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Unwanted Heparin Removed from Blood

By LabMedica International staff writers
Posted on 11 Nov 2008
A new approach for removing unwanted heparin from blood involves the use of microscopic beads of a polymer made from chitosan, a material obtained from shellfish. More...


Polymeric microspheres were obtained by the cross-linking of chitosan using genipin. In laboratory tests, the beads reduced concentrations of heparin to nearly zero within 10 minutes.

A main advantage of the polymeric system is that all of the basic reagents used to prepare the microspheres (chitosan, genipin, and surfactants) are inexpensive and nontoxic. The rate of heparin removal can be adjusted by changing the pH in a wide range. In order to enable heparin removal at higher pH values, cationically-modified chitosan microspheres resulted in a high rate of heparin removal, even at the pH value that is typical of blood (circa 7.4)--this enables even more medical applications of the polymer.

Doctors frequently need to remove heparin from the blood of patients who have undergone surgery or other procedures immediately after completing the procedure. If this is not done the heparin alone could lead to unwanted bleeding. Currently patients are given protamine, a drug that stops heparin's anticoagulant effects. However, protamine itself can cause serious adverse effects

The new polymer material was described by Krzysztof Szczubialka Ph.D., from the Jagiellonian University (Krakow, Poland), and colleagues in the December 8, 2008 issue of the American Chemical Society journal Biomacromolecules.

Related Links:
Jagiellonian University




Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.